2 results match your criteria: "The National Ribat University Khartoum[Affiliation]"
Sodium glucose co-transport 2 inhibitors for gout treatment.
Discoveries (Craiova)
September 2022
Atlantic University School of Medicine, Gross Islet, St. Lucia.
Hyperuricemia remains the most prevalent cause of gout. Gout patients present with joint inflammation and uric acid crystals deposition manifesting as tophi. The association of gout with increased risk of insulin resistance, diabetes, metabolic disorders, increased cardiometabolic risk, and kidney disease is well established.
View Article and Find Full Text PDFArticle Synopsis
- Polycystic ovary syndrome (PCOS) is a common hormonal disorder in premenopausal women, characterized by irregular menstruation, ovulation issues, and excess androgen levels, often linked with insulin resistance and various metabolic disorders.
- Current treatments like metformin show limited effectiveness, highlighting the need for new therapies.
- Novel antidiabetic drugs, such as sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, may offer benefits for PCOS patients by improving weight loss, insulin resistance, and cardiovascular health, but more research is needed on their safety and efficacy in this context.